Physician profile
Garah E Wright
NPI 1295783884
$5,580.14
in general payments reported to CMS, 2019-2025
45 companies · $1,072 in 2025
The $1,072 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $419 · 2021: $761 · 2022: $589 · 2023: $836 · 2024: $1,142 · 2025: $1,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,049.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,115.13 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals Lp | $489.98 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $432.12 | 2019-2025 | |
| Novo Nordisk INC | $424.03 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $340.68 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Allergan, INC. | $272.94 | 2019-2020 | |
| Amgen INC. | $248.38 | 2019-2025 | Prolia, Evenity, Repatha |
| Glaxosmithkline, LLC. | $185.22 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Corium, LLC | $145.56 | 2022-2025 | Azstarys |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.66 | 2019-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $118.64 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $112.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $107.47 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.14 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $98.89 | 2019-2025 | Gardasil 9, Vaxelis, Capvaxive |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garah Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.